Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
CD163+ macrophages restrain vascular calcification, promoting the development of high-risk plaque
Atsushi Sakamoto, … , Renu Virmani, Aloke V. Finn
Atsushi Sakamoto, … , Renu Virmani, Aloke V. Finn
Published January 31, 2023
Citation Information: JCI Insight. 2023;8(5):e154922. https://doi.org/10.1172/jci.insight.154922.
View: Text | PDF
Research Article Cell biology Vascular biology

CD163+ macrophages restrain vascular calcification, promoting the development of high-risk plaque

  • Text
  • PDF
Abstract

Vascular calcification (VC) is concomitant with atherosclerosis, yet it remains uncertain why rupture-prone high-risk plaques do not typically show extensive calcification. Intraplaque hemorrhage (IPH) deposits erythrocyte-derived cholesterol, enlarging the necrotic core and promoting high-risk plaque development. Pro-atherogenic CD163+ alternative macrophages engulf hemoglobin:haptoglobin (HH) complexes at IPH sites. However, their role in VC has never been examined to our knowledge. Here we show, in human arteries, the distribution of CD163+ macrophages correlated inversely with VC. In vitro experiments using vascular smooth muscle cells (VSMCs) cultured with HH-exposed human macrophage — M(Hb) — supernatant reduced calcification, while arteries from ApoE–/– CD163–/– mice showed greater VC. M(Hb) supernatant–exposed VSMCs showed activated NF-κB, while blocking NF-κB attenuated the anticalcific effect of M(Hb) on VSMCs. CD163+ macrophages altered VC through NF-κB–induced transcription of hyaluronan synthase (HAS), an enzyme that catalyzes the formation of the extracellular matrix glycosaminoglycan, hyaluronan, within VSMCs. M(Hb) supernatants enhanced HAS production in VSMCs, while knocking down HAS attenuated its anticalcific effect. NF-κB blockade in ApoE–/– mice reduced hyaluronan and increased VC. In human arteries, hyaluronan and HAS were increased in areas of CD163+ macrophage presence. Our findings highlight an important mechanism by which CD163+ macrophages inhibit VC through NF-κB–induced HAS augmentation and thus promote the high-risk plaque development.

Authors

Atsushi Sakamoto, Rika Kawakami, Masayuki Mori, Liang Guo, Ka Hyun Paek, Jose Verdezoto Mosquera, Anne Cornelissen, Saikat Kumar B. Ghosh, Kenji Kawai, Takao Konishi, Raquel Fernandez, Daniela T. Fuller, Weili Xu, Aimee E. Vozenilek, Yu Sato, Hiroyuki Jinnouchi, Sho Torii, Adam W. Turner, Hirokuni Akahori, Salome Kuntz, Craig C. Weinkauf, Parker J. Lee, Robert Kutys, Kathryn Harris, Alfred Lawrence Killey, Christina M. Mayhew, Matthew Ellis, Leah M. Weinstein, Neel V. Gadhoke, Roma Dhingra, Jeremy Ullman, Armella Dikongue, Maria E. Romero, Frank D. Kolodgie, Clint L. Miller, Renu Virmani, Aloke V. Finn

×

Figure 5

Stimulation of NF-κB signaling by M(Hb) supernatants directs its anticalcific effect on HASMCs.

Options: View larger image (or click on image) Download as PowerPoint
Stimulation of NF-κB signaling by M(Hb) supernatants directs its antical...
(A and B) Representative immunoblotting and summary of densitometry analysis for HASMCs after exposure to M(con) or M(Hb) supernatants for 24 hours without OS: p-p65/t-p65 (whole-cell lysate, n = 4 per group) (A) and t-p65/TBP (nuclear fraction, n = 3 per group) (B). (C–E) Immunoblotting image of t-p65/β-actin for HASMC whole-cell lysate transfected with the scrambled control siRNA or p65-siRNA (C). M(con)sup or M(Hb)sup with OS exposure (48 hours) was performed. Representative AR staining images (D) and summary of % AR-positive area (n = 4 per group) (E). (F) HASMC were exposed to M(con)sup or M(Hb)sup with CTLpep or NBDpep (both 25 μM) without OS for 24-hours. Representative WB images and summary of densitometry analysis for p-p65/t-p65 (whole-cell lysate, n = 3 per group). (G and H) HASMCs were exposed to M(con)sup or M(Hb)sup with OS and CTLpep or NBDpep (6.25, 25, and 100 μM) for 48 hours. Representative AR staining images (G) and summary of % AR-positive area (n = 3 per group) (H). *P < 0.05, **P < 0.01, †P < 0.05 vs. M(con) CTLpep 6.25 μM, ‡P < 0.05 vs. M(con) CTLpep 25 μM, §P 0.05 vs. CTLpep 100 μM, ||P < 0.05 vs. M(Hb) CTLpep 25 μM, ¶P < 0.05 vs. M(Hb) CTLpep 100 μM. Results are presented as the mean ± standard error (A, B, E, F, and H). T test was applied to A and B. ANOVA followed by post hoc Tukey’s test was applied to E, F, and H. Data normality was tested by Shapiro-Wilk test. All experiments were performed at least 3 times to confirm the reproducibility. CTLpep, IKK-NBD control peptide; NBDpep, NF-κB inhibitor NBD peptide; OS, osteogenic medium; p-p65, phosphorylated p65 (Ser536); t-p65, total-p65; Scr, scrambled control siRNA; si p65, p65-siRNA; TBP, TATA-binding protein; WB, Western blotting.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts